Vycor Medical Company Profile (OTCMKTS:VYCO)

About Vycor Medical (OTCMKTS:VYCO)

Vycor Medical logoVycor Medical, Inc. provides surgical and therapeutic solutions. The Company operates through two segments: Vycor Medical, which focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals, and NovaVision, which focuses on neuro-stimulation therapies and diagnostic devices for the treatment and screening of vision field loss resulting from neurological damage. The Company designs, develops and markets neurological medical devices and therapies. The Company operates in the United States and Europe. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. VBAS is a disposable product that can be used with microscopic, endoscopic and neuro-navigation systems. NovaVision has a family of therapies that both restore and compensate for lost vision. NovaVision's products include VRT and Neuro-Eye Therapy (NeET), NeuroEyeCoach and Vision Diagnostic (VIDIT).

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:VYCO
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $2.71 million
  • Outstanding Shares: 17,415,000
Average Prices:
  • 50 Day Moving Avg: $0.19
  • 200 Day Moving Avg: $0.26
  • 52 Week Range: $0.12 - $0.60
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $1.45 million
  • Price / Sales: 1.87
  • Book Value: $0.00 per share
  • Price / Book: -77.75
Profitability:
  • EBIDTA: ($1,320,000.00)
Misc:
  • Average Volume: 2,108 shs.
 

Frequently Asked Questions for Vycor Medical (OTCMKTS:VYCO)

What is Vycor Medical's stock symbol?

Vycor Medical trades on the OTCMKTS under the ticker symbol "VYCO."

Who are some of Vycor Medical's key competitors?

How do I buy Vycor Medical stock?

Shares of Vycor Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Vycor Medical stock cost?

One share of Vycor Medical stock can currently be purchased for approximately $0.16.

Analyst Ratings

Consensus Ratings for Vycor Medical (OTCMKTS:VYCO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Vycor Medical (OTCMKTS:VYCO)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Vycor Medical (OTCMKTS:VYCO)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Vycor Medical (OTCMKTS:VYCO)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Vycor Medical (OTCMKTS:VYCO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Vycor Medical (OTCMKTS:VYCO)
Insider Trades by Quarter for Vycor Medical (OTCMKTS:VYCO)
Insider Trades by Quarter for Vycor Medical (OTCMKTS:VYCO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/31/2014Fountainhead Capital ManagemenMajor ShareholderBuy8,380$1.79$15,000.20View SEC Filing  
10/6/2014Fountainhead Capital ManagemenMajor ShareholderBuy6,383$2.35$15,000.05View SEC Filing  
6/30/2014Fountainhead Capital ManagemenMajor ShareholderBuy6,329$1.80$11,392.20View SEC Filing  
3/31/2014Fountainhead Capital ManagemenMajor ShareholderBuy6,276$1.80$11,296.80View SEC Filing  
1/2/2014Fountainhead Capital ManagemenMajor ShareholderBuy792,523$1.80$1,426,541.40View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Vycor Medical (OTCMKTS:VYCO)
Latest Headlines for Vycor Medical (OTCMKTS:VYCO)
Source:
DateHeadline
finance.yahoo.com logoVycor Medical Reports Financial Results for the Period Ended March 31st, 2017
finance.yahoo.com - May 12 at 4:22 AM
finance.yahoo.com logoVycor Medical, Inc. :VYCO-US: Earnings Analysis: Q4, 2016 By the Numbers : April 11, 2017
finance.yahoo.com - April 11 at 9:35 PM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 10-K, Annual Report
biz.yahoo.com - April 1 at 9:58 AM
finance.yahoo.com logoVycor Medical Reports Financial Results for the Year Ended December 31st, 2016
finance.yahoo.com - April 1 at 9:58 AM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit
biz.yahoo.com - January 13 at 5:55 AM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal
biz.yahoo.com - November 14 at 8:33 PM
finance.yahoo.com logoVycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2016
finance.yahoo.com - November 14 at 12:35 PM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 10-K/A, Annual Report
biz.yahoo.com - November 8 at 8:18 PM
finance.yahoo.com logoNew Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency
finance.yahoo.com - September 28 at 7:49 PM
finance.yahoo.com logoVycor Medical Reports Financial Results for the Three Months Ended March 31st, 2016
finance.yahoo.com - April 28 at 9:00 AM
finance.yahoo.com logoVycor Medical Reports Financial Results for the Year Ended December 31st, 2015
finance.yahoo.com - March 30 at 9:56 AM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - March 30 at 8:31 AM
finance.yahoo.com logoVycor Medical Launches VBASMini
finance.yahoo.com - March 16 at 9:43 AM
finance.yahoo.com logoVYCOR MEDICAL INC Financials
finance.yahoo.com - December 8 at 1:18 PM
finance.yahoo.com logoVycor Medical's NovaVision Launches its European Internet-Delivered Therapy Suite at the 3rd European Conference of NeuroRehabilitation
finance.yahoo.com - November 30 at 8:00 AM
finance.yahoo.com logoNew Clinical Data Released at the World Congress of Neuroendoscopy Conclusively Points to Vycor's VBAS Reducing Post Operative Patient Length of Stay in Hospital
finance.yahoo.com - November 18 at 8:02 AM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
biz.yahoo.com - November 13 at 2:23 PM
finance.yahoo.com logoVycor Medical Reports Third Quarter 2015 Results
finance.yahoo.com - November 13 at 8:30 AM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 13 at 7:33 AM
finance.yahoo.com logoNew Clinical Data in Japan Demonstrates Benefits of Using Vycor Medical's VBAS with Karl Storz's VITOM Exoscope for Surgery of Deep-Seated Tumors
finance.yahoo.com - October 28 at 8:00 AM
finance.yahoo.com logoVycor Medical's NovaVision Unveils Its European Internet-Delivered Therapy Suite at the 30th Annual GNP Conference
finance.yahoo.com - September 30 at 8:30 AM
finance.yahoo.com logoVycor Medical to Unveil VBAS Product Line Extension and Prototypes at CNS 65th Annual Meeting in New Orleans, September 26-30, 2015
finance.yahoo.com - September 25 at 8:30 AM
finance.yahoo.com logoVycor Medical to Present at the 4th Annual Liolios Gateway Conference on September 10, 2015
finance.yahoo.com - August 31 at 8:31 AM
finance.yahoo.com logoVycor Medical Reports Second Quarter 2015 Results
finance.yahoo.com - August 14 at 5:00 PM
finance.yahoo.com logoWorld Neurosurgery Publishes New Clinical Study Performed at the Walter Reed National Military Medical Center Showing Positive Performance of Vycor's VBAS in the Treatment of Wartime Brain Injuries
finance.yahoo.com - August 12 at 10:10 AM
biz.yahoo.com logoVYCOR MEDICAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - July 24 at 4:37 PM

Social

Chart

Vycor Medical (VYCO) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff